Evaluating a Therapeutic Association Between CMV-specific Immunoglobulin Infusion and Pre-transplant CD16-expressing Gamma Delta Vdelta 2 Negative T-cells in CMV-positive Patients for Preventive Treatment of CMV Infection in Renal Transplantation
Latest Information Update: 19 Jul 2023
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- Acronyms SYNTAGME
- 17 Jul 2023 Planned End Date changed from 1 Nov 2023 to 1 May 2025.
- 17 Jul 2023 Planned primary completion date changed from 1 Nov 2023 to 1 May 2025.
- 18 Nov 2021 Planned End Date changed from 1 Jun 2023 to 1 Nov 2023.